Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks
Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
[HTML][HTML] Utilizing biologics in drug desensitization
BC Yang, MC Castells - Current Allergy and Asthma Reports, 2023 - Springer
Abstract Purpose of Review The purpose of this literature review was to review the latest
advancements with biologics in rapid drug desensitization. Our methodology was to …
advancements with biologics in rapid drug desensitization. Our methodology was to …
What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later
AM Copaescu, JSR Duque, EJ Phillips - Annals of Allergy, Asthma & …, 2022 - Elsevier
Objective The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the most rapid response and …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to the most rapid response and …
Identifying and managing those at risk for vaccine-related allergy and anaphylaxis
CA Stone Jr, LH Garvey, S Nasser, C Lever… - The Journal of Allergy …, 2023 - Elsevier
Immediate hypersensitivity reactions to vaccines, the most severe of which is anaphylaxis,
are uncommon events occurring in fewer than 1 in a million doses administered. These …
are uncommon events occurring in fewer than 1 in a million doses administered. These …
Anaphylaxis and Related Events Following COVID‐19 Vaccination: A Systematic Review
P Paul, E Janjua, M AlSubaie… - The Journal of …, 2022 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), induced by the severe acute
respiratory syndrome coronavirus 2, is responsible for a global pandemic following …
respiratory syndrome coronavirus 2, is responsible for a global pandemic following …
[HTML][HTML] Protection against Severe Illness versus Immunity—Redefining Vaccine Effectiveness in the Aftermath of COVID-19
Anti-SARS-CoV-2 vaccines have played a pivotal role in reducing the risk of developing
severe illness from COVID-19, thus helping end the COVID-19 global public health …
severe illness from COVID-19, thus helping end the COVID-19 global public health …
Allergic reactions to the coronavirus disease 2019 vaccine (ARCOV) study: the McGill University Health Centre experience
F ALMuhizi, M Fein, S Gabrielli, L Gilbert… - Annals of Allergy …, 2022 - Elsevier
Background Messenger RNA coronavirus disease 2019 (COVID-19) vaccines have been
associated with allergic reactions. A history of anaphylaxis has been suggested as a risk …
associated with allergic reactions. A history of anaphylaxis has been suggested as a risk …
[HTML][HTML] Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
MR Messina, C Crisciotti, L Pellegrini, E Nappi… - Vaccines, 2023 - mdpi.com
Vaccines for SAR-CoV-2 are the most effective preventive treatment able to reduce the risk
of contracting the infection and experiencing worse outcomes whenever the infection is …
of contracting the infection and experiencing worse outcomes whenever the infection is …
[HTML][HTML] Adverse reactions to anti-infective vaccines: an emerging problem in the COVID-19 era
C Escudero, P Prieto-Montaño… - Current Treatment Options …, 2022 - Springer
Purpose of review Vaccines are an essential tool for preventing infectious diseases and
reducing associated morbidity and mortality. Vaccination has a significant impact at both …
reducing associated morbidity and mortality. Vaccination has a significant impact at both …
[HTML][HTML] Fractionated vaccination with mRNA COVID‐19 vaccine is safe for patients with polyethylene glycol allergy
CG Mortz, HF Kjaer, TK Georgsen… - Clinical and …, 2023 - ncbi.nlm.nih.gov
To the editor The safety of COVID‐19 vaccinations in polyethylene glycol (PEG) allergic
patients is a challenge as PEG is an excipient in several mRNA vaccines including …
patients is a challenge as PEG is an excipient in several mRNA vaccines including …